Review



anti pan ampar  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anti pan ampar
    Anti Pan Ampar, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/AMPA+Receptor+(GluA2%2F3%2F4)+Antibody/pm41872515-78-48-51
    Average 93 stars, based on 31 article reviews
    anti pan ampar - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Confocal Microscopy:

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti-α-tubulin (PTM, 5442, 1:10000), anti-β-actin (Abclonal, AC026, 1:10000), anti-Caspase-3 (Cell Signaling Technology, 9662S, 1:1000), anti-Cleaved-Caspase3 (Cell Signaling Technology, 9664S, 1:1000), anti-Cleaved-PARP (Cell Signaling Technology, 9544S, 1:1000), anti-GLAST (Proteintech, 20785-1-AP, 1:1000), anti-GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti-GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti-GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti-GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti-GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-p-GSK3β (Proteintech, 17517-1-AP, 1:1000), anti-GYS1 (4A biotech, 4ab086436, 1:1000), anti-PARP (Cell Signaling Technology, 9532S, 1:1000), anti-PSD93 (Abcam, ab94588, 1:1000), anti-PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti-PYGB (4A biotech, 4ab093844, 1:1000), anti-PYGL (4A biotech, 4ab094049, 1:1000), anti-PYGM (Abcam, ab231963, 1:1000), RESEARCH INCONTEXT 1. .. Systematic review: We reviewed prior studies examining astrocytic metabolism in neurodegenerati

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate‐mediated neuroprotection
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti‐α‐tubulin (PTM, 5442, 1:10000), anti‐β‐actin (Abclonal, AC026, 1:10000), anti‐Caspase‐3 (Cell Signaling Technology, 9662S, 1:1000), anti‐Cleaved‐Caspase‐3 (Cell Signaling Technology, 9664S, 1:1000), anti‐Cleaved‐PARP (Cell Signaling Technology, 9544S, 1:1000), anti‐GLAST (Proteintech, 20785‐1‐AP, 1:1000), anti‐GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti‐GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti‐GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti‐GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti‐GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐p‐GSK3β (Proteintech, 17517‐1‐AP, 1:1000), anti‐GYS1 (4A biotech, 4ab086436, 1:1000), anti‐PARP (Cell Signaling Technology, 9532S, 1:1000), anti‐PSD93 (Abcam, ab94588, 1:1000), anti‐PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti‐PYGB (4A biotech, 4ab093844, 1:1000), anti‐PYGL (4A biotech, 4ab094049, 1:1000), anti‐PYGM (Abcam, ab231963, 1:1000), anti‐p‐Tau T181 (Cell Signaling Technology, 12885S, 1:1000), anti‐p‐Tau S199 (Invitrogen, 44734G, 1:1000), anti‐p‐Tau T205 (Biosource, 44‐738G, 1:1000), anti‐p‐Tau T212 (Biosource, 44‐740G, 1:1000), anti‐p‐Tau T231/S235 (Cell Signaling Technology, 20473S, 1:1000), anti‐p‐Tau S396 (Invitrogen, 44752G, 1:1000), anti‐p‐Tau S404 (Cell Signaling Technology, 20194S, 1:1000), and anti‐total tau (Invitrogen, AHB0042, 1:1000). .. Original immunoblot data are provided in Figure .

    Article Title: TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti-β-actin (CST, 8457S, 1:2000), anti-ATF6 (Abcam, ab227830, 1:1000), anti-BiP (CST, C50B12, 1:1000), antiCDK5 (Santa Cruz, sc-173, 1:1000), anti-Flag (Proteintech, 20543- 1-AP, 1:1000), anti-GAPDH (Abways, AB0038, 1:5000), anti-GFAP (Cell Signaling Technology, 3670S, 1:1000), anti-GFP (Proteintech, 50430-2-AP, 1:1000), anti-GluA2 (CST, 13607S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-HA (Proteintech, S1064-2AP, 1:1000), anti-HSC70 (Proteintech, 10654-1-AP, 1:1000), anti-Iba1 (Wako, 016-20001, 1:500), anti-LAMP2A (Abcam, ab18528, 1:1000), anti-LC3B (CST, 3868, 1:500), anti-myc (CST, 2276S, 1:1000), antip35/25 (CST, 2680, 1:1000), anti-PERK (CST, D11A8, 1:1000), antiPP1α (Thermo, 43-8100, 1:1000), anti-PP2A-α (ABclonal, A6702, 1:1000), anti-PP2B-Aα (Santa Cruz, sc-17808, 1:1000), anti-pPERK (CST, 16F8, 1:1000), anti-pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti-pS212 tau (Biosource, 44-740G, 1:1000), anti-pS396 tau (Invitrogen, 44752G, 1:1000), anti-pT216-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti-TMEM59 (ABclonal, WG-03224D, 1:1000), and antiXBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase-conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: TMEM59 deficiency activates chaperone‐mediated autophagy and ameliorates disease‐like pathologies in tauopathy model mice
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti‐β‐actin (CST, 8457S, 1:2000), anti‐ATF6 (Abcam, ab227830, 1:1000), anti‐BiP (CST, C50B12, 1:1000), anti‐CDK5 (Santa Cruz, sc‐173, 1:1000), anti‐Flag (Proteintech, 20543‐1‐AP, 1:1000), anti‐GAPDH (Abways, AB0038, 1:5000), anti‐GFAP (Cell Signaling Technology, 3670S, 1:1000), anti‐GFP (Proteintech, 50430‐2‐AP, 1:1000), anti‐GluA2 (CST, 13607S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐HA (Proteintech, S1064‐2‐AP, 1:1000), anti‐HSC70 (Proteintech, 10654‐1‐AP, 1:1000), anti‐Iba1 (Wako, 016‐20001, 1:500), anti‐LAMP2A (Abcam, ab18528, 1:1000), anti‐LC3B (CST, 3868, 1:500), anti‐myc (CST, 2276S, 1:1000), anti‐p35/25 (CST, 2680, 1:1000), anti‐PERK (CST, D11A8, 1:1000), anti‐PP1α (Thermo, 43‐8100, 1:1000), anti‐PP2A‐α (ABclonal, A6702, 1:1000), anti‐PP2B‐Aα (Santa Cruz, sc‐17808, 1:1000), anti‐pPERK (CST, 16F8, 1:1000), anti‐pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti‐pS212 tau (Biosource, 44‐740G, 1:1000), anti‐pS396 tau (Invitrogen, 44752G, 1:1000), anti‐pT216‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti‐TMEM59 (ABclonal, WG‐03224D, 1:1000), and anti‐XBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase‐conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure
    Article Snippet: Finally, protein visualization was conducted using the AI-800 imaging system (General Electric Company, United States), and the optical density values of each band were quantitatively analyzed using ImageJ software.and the optical density values of each band were quantitatively analyzed using ImageJ software. ... Primary antibody with the following proteins: anti-p-PKA (Ser133, 5661, 1:1,000, Cell Signaling Technology); anti-PKA (ab32514, 1:1,000, Abcam); anti-p-CREB (Ser133, ab32096, 1:1,000, Abcam); manti-CREB (ab32515, 1:1,000, Abcam); anti-BDNF (ab108319, 1:1,000, Abcam); anti-p-TrkB (ab229908, 1:1,000, Abcam); anti-TrkB (ab187041, 1:2,000, Abcam); anti-PSD95 (20665-1-AP, 1:1,000, Proteintech); anti-Synaptophysin (36406S, 1:1,000, Cell Signaling Technology); anti-NR2A (ab124913, 1:1,000, Abcam); anti-NR2B (ab65783, 1; 1,000, Abcam); anti-GluA1 (13185S, 1:1,000, Cell Signaling Technology); anti-GluA2 (13607S, 1:1,000, Cell Signaling Technology); anti-β-tubulin (AC021, 1:5,000, ABclonal); anti-GAPDH (60004-1-Ig, 1:5,000, Proteintech).

    Article Title: Metaplastic priming enables non-ionotropic NMDA receptor-mediated synaptic depotentiation in the hippocampus
    Article Snippet: Membranes were briefly stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature.stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature. ... The blotted proteins were then probed with moloclonal anti-GluA1 (1:1000, Cell Signaling Technology (CST), Danvers, Massachusetts, United States, cat nr #13185, RRID: AB_2732897), anti-GluA2 (1:1000, CST, cat nr #13607, RRID: AB_2650557), anit-GluA1-Ser831 (1:1000, CST, 75574, RRID: AB_2799873), anti-GluA1-Ser845 (1:1000, CST, 8084, RRID: AB_10860773) or anti-GAPDH (1:12000, CST, cat nr #2118, RRID: AB_561053) overnight at 4 0 C in 5% bovine serum albumin (BSA) in TBS-T.. Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).

    Article Title: Chronic stress induces Alzheimer’s disease-like pathologies through DNA damage-Chk1-CIP2A signaling
    Article Snippet: The primary antibodies used in this research were as follows: anti-γH2A.X (ab26350, Abcam; 80312S, Cell Signaling Technology), anti-NeuN (26975-1-AP, Proteintech), anti-GFAP (12389S, Cell Signaling Technology), anti-Iba1 (ab178846, Abcam), anti-Chk1-pS317 (12302S, Cell Signaling Technology), anti-Chk1-pS345 (39233, Gene Tex; A21009, Abclonal), anti-Chk1 (A7653, Abclonal), anti-CIP2A (A12267, Abclonal), anti-Tau-pT231 (R381181, Zen-Bioscience), anti-Tau-pS396 (381213, Zen-Bioscience), anti-Tau-pS404 (11112, SAB), Tau-5 (ab80579, Abcam), anti-APP-pT668 (6986S, Cell Signaling Technology), anti-APP (60,342–1-Ig, Proteintech), anti-PSD95 (36233S, Cell Signaling Technology; 30255-1-AP, Proteintech), anti-Synapsin- I (5297S, Cell Signaling Technology), anti-GluA1 (13185S, Cell Signaling Technology), anti-GluA2 (13607S, Cell Signaling Technology), anti-β-actin (AC026, Abclonal).. The second antibodies for Western blotting were purchased from LICOR-Biosciences (Cat#926-32210, IRDye-800CW Goat anti-Mouse IgG Secondary Antibody; Cat#926-32211, IRDye-800CW Goat anti-Rabbit IgG Secondary Antibody).

    Article Title: Chronic Lithium Treatment Alters NMDA and AMPA Receptor Synaptic Availability and Dendritic Spine Organization in the Rat Hippocampus
    Article Snippet: 9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.. 13185, RRID: AB_2732897), anti-GluA2 (1:1000, Cell Signaling Technology, cod.. 5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.

    Staining:

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti-α-tubulin (PTM, 5442, 1:10000), anti-β-actin (Abclonal, AC026, 1:10000), anti-Caspase-3 (Cell Signaling Technology, 9662S, 1:1000), anti-Cleaved-Caspase3 (Cell Signaling Technology, 9664S, 1:1000), anti-Cleaved-PARP (Cell Signaling Technology, 9544S, 1:1000), anti-GLAST (Proteintech, 20785-1-AP, 1:1000), anti-GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti-GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti-GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti-GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti-GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-p-GSK3β (Proteintech, 17517-1-AP, 1:1000), anti-GYS1 (4A biotech, 4ab086436, 1:1000), anti-PARP (Cell Signaling Technology, 9532S, 1:1000), anti-PSD93 (Abcam, ab94588, 1:1000), anti-PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti-PYGB (4A biotech, 4ab093844, 1:1000), anti-PYGL (4A biotech, 4ab094049, 1:1000), anti-PYGM (Abcam, ab231963, 1:1000), RESEARCH INCONTEXT 1. .. Systematic review: We reviewed prior studies examining astrocytic metabolism in neurodegenerati

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate‐mediated neuroprotection
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti‐α‐tubulin (PTM, 5442, 1:10000), anti‐β‐actin (Abclonal, AC026, 1:10000), anti‐Caspase‐3 (Cell Signaling Technology, 9662S, 1:1000), anti‐Cleaved‐Caspase‐3 (Cell Signaling Technology, 9664S, 1:1000), anti‐Cleaved‐PARP (Cell Signaling Technology, 9544S, 1:1000), anti‐GLAST (Proteintech, 20785‐1‐AP, 1:1000), anti‐GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti‐GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti‐GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti‐GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti‐GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐p‐GSK3β (Proteintech, 17517‐1‐AP, 1:1000), anti‐GYS1 (4A biotech, 4ab086436, 1:1000), anti‐PARP (Cell Signaling Technology, 9532S, 1:1000), anti‐PSD93 (Abcam, ab94588, 1:1000), anti‐PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti‐PYGB (4A biotech, 4ab093844, 1:1000), anti‐PYGL (4A biotech, 4ab094049, 1:1000), anti‐PYGM (Abcam, ab231963, 1:1000), anti‐p‐Tau T181 (Cell Signaling Technology, 12885S, 1:1000), anti‐p‐Tau S199 (Invitrogen, 44734G, 1:1000), anti‐p‐Tau T205 (Biosource, 44‐738G, 1:1000), anti‐p‐Tau T212 (Biosource, 44‐740G, 1:1000), anti‐p‐Tau T231/S235 (Cell Signaling Technology, 20473S, 1:1000), anti‐p‐Tau S396 (Invitrogen, 44752G, 1:1000), anti‐p‐Tau S404 (Cell Signaling Technology, 20194S, 1:1000), and anti‐total tau (Invitrogen, AHB0042, 1:1000). .. Original immunoblot data are provided in Figure .

    Article Title: TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti-β-actin (CST, 8457S, 1:2000), anti-ATF6 (Abcam, ab227830, 1:1000), anti-BiP (CST, C50B12, 1:1000), antiCDK5 (Santa Cruz, sc-173, 1:1000), anti-Flag (Proteintech, 20543- 1-AP, 1:1000), anti-GAPDH (Abways, AB0038, 1:5000), anti-GFAP (Cell Signaling Technology, 3670S, 1:1000), anti-GFP (Proteintech, 50430-2-AP, 1:1000), anti-GluA2 (CST, 13607S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-HA (Proteintech, S1064-2AP, 1:1000), anti-HSC70 (Proteintech, 10654-1-AP, 1:1000), anti-Iba1 (Wako, 016-20001, 1:500), anti-LAMP2A (Abcam, ab18528, 1:1000), anti-LC3B (CST, 3868, 1:500), anti-myc (CST, 2276S, 1:1000), antip35/25 (CST, 2680, 1:1000), anti-PERK (CST, D11A8, 1:1000), antiPP1α (Thermo, 43-8100, 1:1000), anti-PP2A-α (ABclonal, A6702, 1:1000), anti-PP2B-Aα (Santa Cruz, sc-17808, 1:1000), anti-pPERK (CST, 16F8, 1:1000), anti-pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti-pS212 tau (Biosource, 44-740G, 1:1000), anti-pS396 tau (Invitrogen, 44752G, 1:1000), anti-pT216-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti-TMEM59 (ABclonal, WG-03224D, 1:1000), and antiXBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase-conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: TMEM59 deficiency activates chaperone‐mediated autophagy and ameliorates disease‐like pathologies in tauopathy model mice
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti‐β‐actin (CST, 8457S, 1:2000), anti‐ATF6 (Abcam, ab227830, 1:1000), anti‐BiP (CST, C50B12, 1:1000), anti‐CDK5 (Santa Cruz, sc‐173, 1:1000), anti‐Flag (Proteintech, 20543‐1‐AP, 1:1000), anti‐GAPDH (Abways, AB0038, 1:5000), anti‐GFAP (Cell Signaling Technology, 3670S, 1:1000), anti‐GFP (Proteintech, 50430‐2‐AP, 1:1000), anti‐GluA2 (CST, 13607S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐HA (Proteintech, S1064‐2‐AP, 1:1000), anti‐HSC70 (Proteintech, 10654‐1‐AP, 1:1000), anti‐Iba1 (Wako, 016‐20001, 1:500), anti‐LAMP2A (Abcam, ab18528, 1:1000), anti‐LC3B (CST, 3868, 1:500), anti‐myc (CST, 2276S, 1:1000), anti‐p35/25 (CST, 2680, 1:1000), anti‐PERK (CST, D11A8, 1:1000), anti‐PP1α (Thermo, 43‐8100, 1:1000), anti‐PP2A‐α (ABclonal, A6702, 1:1000), anti‐PP2B‐Aα (Santa Cruz, sc‐17808, 1:1000), anti‐pPERK (CST, 16F8, 1:1000), anti‐pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti‐pS212 tau (Biosource, 44‐740G, 1:1000), anti‐pS396 tau (Invitrogen, 44752G, 1:1000), anti‐pT216‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti‐TMEM59 (ABclonal, WG‐03224D, 1:1000), and anti‐XBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase‐conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure
    Article Snippet: Finally, protein visualization was conducted using the AI-800 imaging system (General Electric Company, United States), and the optical density values of each band were quantitatively analyzed using ImageJ software.and the optical density values of each band were quantitatively analyzed using ImageJ software. ... Primary antibody with the following proteins: anti-p-PKA (Ser133, 5661, 1:1,000, Cell Signaling Technology); anti-PKA (ab32514, 1:1,000, Abcam); anti-p-CREB (Ser133, ab32096, 1:1,000, Abcam); manti-CREB (ab32515, 1:1,000, Abcam); anti-BDNF (ab108319, 1:1,000, Abcam); anti-p-TrkB (ab229908, 1:1,000, Abcam); anti-TrkB (ab187041, 1:2,000, Abcam); anti-PSD95 (20665-1-AP, 1:1,000, Proteintech); anti-Synaptophysin (36406S, 1:1,000, Cell Signaling Technology); anti-NR2A (ab124913, 1:1,000, Abcam); anti-NR2B (ab65783, 1; 1,000, Abcam); anti-GluA1 (13185S, 1:1,000, Cell Signaling Technology); anti-GluA2 (13607S, 1:1,000, Cell Signaling Technology); anti-β-tubulin (AC021, 1:5,000, ABclonal); anti-GAPDH (60004-1-Ig, 1:5,000, Proteintech).

    Article Title: Metaplastic priming enables non-ionotropic NMDA receptor-mediated synaptic depotentiation in the hippocampus
    Article Snippet: Membranes were briefly stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature.stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature. ... The blotted proteins were then probed with moloclonal anti-GluA1 (1:1000, Cell Signaling Technology (CST), Danvers, Massachusetts, United States, cat nr #13185, RRID: AB_2732897), anti-GluA2 (1:1000, CST, cat nr #13607, RRID: AB_2650557), anit-GluA1-Ser831 (1:1000, CST, 75574, RRID: AB_2799873), anti-GluA1-Ser845 (1:1000, CST, 8084, RRID: AB_10860773) or anti-GAPDH (1:12000, CST, cat nr #2118, RRID: AB_561053) overnight at 4 0 C in 5% bovine serum albumin (BSA) in TBS-T.. Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).

    Article Title: Chronic stress induces Alzheimer’s disease-like pathologies through DNA damage-Chk1-CIP2A signaling
    Article Snippet: The primary antibodies used in this research were as follows: anti-γH2A.X (ab26350, Abcam; 80312S, Cell Signaling Technology), anti-NeuN (26975-1-AP, Proteintech), anti-GFAP (12389S, Cell Signaling Technology), anti-Iba1 (ab178846, Abcam), anti-Chk1-pS317 (12302S, Cell Signaling Technology), anti-Chk1-pS345 (39233, Gene Tex; A21009, Abclonal), anti-Chk1 (A7653, Abclonal), anti-CIP2A (A12267, Abclonal), anti-Tau-pT231 (R381181, Zen-Bioscience), anti-Tau-pS396 (381213, Zen-Bioscience), anti-Tau-pS404 (11112, SAB), Tau-5 (ab80579, Abcam), anti-APP-pT668 (6986S, Cell Signaling Technology), anti-APP (60,342–1-Ig, Proteintech), anti-PSD95 (36233S, Cell Signaling Technology; 30255-1-AP, Proteintech), anti-Synapsin- I (5297S, Cell Signaling Technology), anti-GluA1 (13185S, Cell Signaling Technology), anti-GluA2 (13607S, Cell Signaling Technology), anti-β-actin (AC026, Abclonal).. The second antibodies for Western blotting were purchased from LICOR-Biosciences (Cat#926-32210, IRDye-800CW Goat anti-Mouse IgG Secondary Antibody; Cat#926-32211, IRDye-800CW Goat anti-Rabbit IgG Secondary Antibody).

    Article Title: Chronic Lithium Treatment Alters NMDA and AMPA Receptor Synaptic Availability and Dendritic Spine Organization in the Rat Hippocampus
    Article Snippet: 9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.. 13185, RRID: AB_2732897), anti-GluA2 (1:1000, Cell Signaling Technology, cod.. 5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.

    Fluorescence:

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti-α-tubulin (PTM, 5442, 1:10000), anti-β-actin (Abclonal, AC026, 1:10000), anti-Caspase-3 (Cell Signaling Technology, 9662S, 1:1000), anti-Cleaved-Caspase3 (Cell Signaling Technology, 9664S, 1:1000), anti-Cleaved-PARP (Cell Signaling Technology, 9544S, 1:1000), anti-GLAST (Proteintech, 20785-1-AP, 1:1000), anti-GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti-GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti-GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti-GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti-GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-p-GSK3β (Proteintech, 17517-1-AP, 1:1000), anti-GYS1 (4A biotech, 4ab086436, 1:1000), anti-PARP (Cell Signaling Technology, 9532S, 1:1000), anti-PSD93 (Abcam, ab94588, 1:1000), anti-PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti-PYGB (4A biotech, 4ab093844, 1:1000), anti-PYGL (4A biotech, 4ab094049, 1:1000), anti-PYGM (Abcam, ab231963, 1:1000), RESEARCH INCONTEXT 1. .. Systematic review: We reviewed prior studies examining astrocytic metabolism in neurodegenerati

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate‐mediated neuroprotection
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti‐α‐tubulin (PTM, 5442, 1:10000), anti‐β‐actin (Abclonal, AC026, 1:10000), anti‐Caspase‐3 (Cell Signaling Technology, 9662S, 1:1000), anti‐Cleaved‐Caspase‐3 (Cell Signaling Technology, 9664S, 1:1000), anti‐Cleaved‐PARP (Cell Signaling Technology, 9544S, 1:1000), anti‐GLAST (Proteintech, 20785‐1‐AP, 1:1000), anti‐GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti‐GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti‐GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti‐GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti‐GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐p‐GSK3β (Proteintech, 17517‐1‐AP, 1:1000), anti‐GYS1 (4A biotech, 4ab086436, 1:1000), anti‐PARP (Cell Signaling Technology, 9532S, 1:1000), anti‐PSD93 (Abcam, ab94588, 1:1000), anti‐PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti‐PYGB (4A biotech, 4ab093844, 1:1000), anti‐PYGL (4A biotech, 4ab094049, 1:1000), anti‐PYGM (Abcam, ab231963, 1:1000), anti‐p‐Tau T181 (Cell Signaling Technology, 12885S, 1:1000), anti‐p‐Tau S199 (Invitrogen, 44734G, 1:1000), anti‐p‐Tau T205 (Biosource, 44‐738G, 1:1000), anti‐p‐Tau T212 (Biosource, 44‐740G, 1:1000), anti‐p‐Tau T231/S235 (Cell Signaling Technology, 20473S, 1:1000), anti‐p‐Tau S396 (Invitrogen, 44752G, 1:1000), anti‐p‐Tau S404 (Cell Signaling Technology, 20194S, 1:1000), and anti‐total tau (Invitrogen, AHB0042, 1:1000). .. Original immunoblot data are provided in Figure .

    Article Title: TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti-β-actin (CST, 8457S, 1:2000), anti-ATF6 (Abcam, ab227830, 1:1000), anti-BiP (CST, C50B12, 1:1000), antiCDK5 (Santa Cruz, sc-173, 1:1000), anti-Flag (Proteintech, 20543- 1-AP, 1:1000), anti-GAPDH (Abways, AB0038, 1:5000), anti-GFAP (Cell Signaling Technology, 3670S, 1:1000), anti-GFP (Proteintech, 50430-2-AP, 1:1000), anti-GluA2 (CST, 13607S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-HA (Proteintech, S1064-2AP, 1:1000), anti-HSC70 (Proteintech, 10654-1-AP, 1:1000), anti-Iba1 (Wako, 016-20001, 1:500), anti-LAMP2A (Abcam, ab18528, 1:1000), anti-LC3B (CST, 3868, 1:500), anti-myc (CST, 2276S, 1:1000), antip35/25 (CST, 2680, 1:1000), anti-PERK (CST, D11A8, 1:1000), antiPP1α (Thermo, 43-8100, 1:1000), anti-PP2A-α (ABclonal, A6702, 1:1000), anti-PP2B-Aα (Santa Cruz, sc-17808, 1:1000), anti-pPERK (CST, 16F8, 1:1000), anti-pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti-pS212 tau (Biosource, 44-740G, 1:1000), anti-pS396 tau (Invitrogen, 44752G, 1:1000), anti-pT216-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti-TMEM59 (ABclonal, WG-03224D, 1:1000), and antiXBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase-conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: TMEM59 deficiency activates chaperone‐mediated autophagy and ameliorates disease‐like pathologies in tauopathy model mice
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti‐β‐actin (CST, 8457S, 1:2000), anti‐ATF6 (Abcam, ab227830, 1:1000), anti‐BiP (CST, C50B12, 1:1000), anti‐CDK5 (Santa Cruz, sc‐173, 1:1000), anti‐Flag (Proteintech, 20543‐1‐AP, 1:1000), anti‐GAPDH (Abways, AB0038, 1:5000), anti‐GFAP (Cell Signaling Technology, 3670S, 1:1000), anti‐GFP (Proteintech, 50430‐2‐AP, 1:1000), anti‐GluA2 (CST, 13607S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐HA (Proteintech, S1064‐2‐AP, 1:1000), anti‐HSC70 (Proteintech, 10654‐1‐AP, 1:1000), anti‐Iba1 (Wako, 016‐20001, 1:500), anti‐LAMP2A (Abcam, ab18528, 1:1000), anti‐LC3B (CST, 3868, 1:500), anti‐myc (CST, 2276S, 1:1000), anti‐p35/25 (CST, 2680, 1:1000), anti‐PERK (CST, D11A8, 1:1000), anti‐PP1α (Thermo, 43‐8100, 1:1000), anti‐PP2A‐α (ABclonal, A6702, 1:1000), anti‐PP2B‐Aα (Santa Cruz, sc‐17808, 1:1000), anti‐pPERK (CST, 16F8, 1:1000), anti‐pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti‐pS212 tau (Biosource, 44‐740G, 1:1000), anti‐pS396 tau (Invitrogen, 44752G, 1:1000), anti‐pT216‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti‐TMEM59 (ABclonal, WG‐03224D, 1:1000), and anti‐XBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase‐conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure
    Article Snippet: Finally, protein visualization was conducted using the AI-800 imaging system (General Electric Company, United States), and the optical density values of each band were quantitatively analyzed using ImageJ software.and the optical density values of each band were quantitatively analyzed using ImageJ software. ... Primary antibody with the following proteins: anti-p-PKA (Ser133, 5661, 1:1,000, Cell Signaling Technology); anti-PKA (ab32514, 1:1,000, Abcam); anti-p-CREB (Ser133, ab32096, 1:1,000, Abcam); manti-CREB (ab32515, 1:1,000, Abcam); anti-BDNF (ab108319, 1:1,000, Abcam); anti-p-TrkB (ab229908, 1:1,000, Abcam); anti-TrkB (ab187041, 1:2,000, Abcam); anti-PSD95 (20665-1-AP, 1:1,000, Proteintech); anti-Synaptophysin (36406S, 1:1,000, Cell Signaling Technology); anti-NR2A (ab124913, 1:1,000, Abcam); anti-NR2B (ab65783, 1; 1,000, Abcam); anti-GluA1 (13185S, 1:1,000, Cell Signaling Technology); anti-GluA2 (13607S, 1:1,000, Cell Signaling Technology); anti-β-tubulin (AC021, 1:5,000, ABclonal); anti-GAPDH (60004-1-Ig, 1:5,000, Proteintech).

    Article Title: Metaplastic priming enables non-ionotropic NMDA receptor-mediated synaptic depotentiation in the hippocampus
    Article Snippet: Membranes were briefly stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature.stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature. ... The blotted proteins were then probed with moloclonal anti-GluA1 (1:1000, Cell Signaling Technology (CST), Danvers, Massachusetts, United States, cat nr #13185, RRID: AB_2732897), anti-GluA2 (1:1000, CST, cat nr #13607, RRID: AB_2650557), anit-GluA1-Ser831 (1:1000, CST, 75574, RRID: AB_2799873), anti-GluA1-Ser845 (1:1000, CST, 8084, RRID: AB_10860773) or anti-GAPDH (1:12000, CST, cat nr #2118, RRID: AB_561053) overnight at 4 0 C in 5% bovine serum albumin (BSA) in TBS-T.. Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).

    Article Title: Chronic stress induces Alzheimer’s disease-like pathologies through DNA damage-Chk1-CIP2A signaling
    Article Snippet: The primary antibodies used in this research were as follows: anti-γH2A.X (ab26350, Abcam; 80312S, Cell Signaling Technology), anti-NeuN (26975-1-AP, Proteintech), anti-GFAP (12389S, Cell Signaling Technology), anti-Iba1 (ab178846, Abcam), anti-Chk1-pS317 (12302S, Cell Signaling Technology), anti-Chk1-pS345 (39233, Gene Tex; A21009, Abclonal), anti-Chk1 (A7653, Abclonal), anti-CIP2A (A12267, Abclonal), anti-Tau-pT231 (R381181, Zen-Bioscience), anti-Tau-pS396 (381213, Zen-Bioscience), anti-Tau-pS404 (11112, SAB), Tau-5 (ab80579, Abcam), anti-APP-pT668 (6986S, Cell Signaling Technology), anti-APP (60,342–1-Ig, Proteintech), anti-PSD95 (36233S, Cell Signaling Technology; 30255-1-AP, Proteintech), anti-Synapsin- I (5297S, Cell Signaling Technology), anti-GluA1 (13185S, Cell Signaling Technology), anti-GluA2 (13607S, Cell Signaling Technology), anti-β-actin (AC026, Abclonal).. The second antibodies for Western blotting were purchased from LICOR-Biosciences (Cat#926-32210, IRDye-800CW Goat anti-Mouse IgG Secondary Antibody; Cat#926-32211, IRDye-800CW Goat anti-Rabbit IgG Secondary Antibody).

    Article Title: Chronic Lithium Treatment Alters NMDA and AMPA Receptor Synaptic Availability and Dendritic Spine Organization in the Rat Hippocampus
    Article Snippet: 9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.. 13185, RRID: AB_2732897), anti-GluA2 (1:1000, Cell Signaling Technology, cod.. 5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.

    Control:

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti-α-tubulin (PTM, 5442, 1:10000), anti-β-actin (Abclonal, AC026, 1:10000), anti-Caspase-3 (Cell Signaling Technology, 9662S, 1:1000), anti-Cleaved-Caspase3 (Cell Signaling Technology, 9664S, 1:1000), anti-Cleaved-PARP (Cell Signaling Technology, 9544S, 1:1000), anti-GLAST (Proteintech, 20785-1-AP, 1:1000), anti-GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti-GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti-GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti-GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti-GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-p-GSK3β (Proteintech, 17517-1-AP, 1:1000), anti-GYS1 (4A biotech, 4ab086436, 1:1000), anti-PARP (Cell Signaling Technology, 9532S, 1:1000), anti-PSD93 (Abcam, ab94588, 1:1000), anti-PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti-PYGB (4A biotech, 4ab093844, 1:1000), anti-PYGL (4A biotech, 4ab094049, 1:1000), anti-PYGM (Abcam, ab231963, 1:1000), RESEARCH INCONTEXT 1. .. Systematic review: We reviewed prior studies examining astrocytic metabolism in neurodegenerati

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate‐mediated neuroprotection
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti‐α‐tubulin (PTM, 5442, 1:10000), anti‐β‐actin (Abclonal, AC026, 1:10000), anti‐Caspase‐3 (Cell Signaling Technology, 9662S, 1:1000), anti‐Cleaved‐Caspase‐3 (Cell Signaling Technology, 9664S, 1:1000), anti‐Cleaved‐PARP (Cell Signaling Technology, 9544S, 1:1000), anti‐GLAST (Proteintech, 20785‐1‐AP, 1:1000), anti‐GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti‐GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti‐GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti‐GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti‐GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐p‐GSK3β (Proteintech, 17517‐1‐AP, 1:1000), anti‐GYS1 (4A biotech, 4ab086436, 1:1000), anti‐PARP (Cell Signaling Technology, 9532S, 1:1000), anti‐PSD93 (Abcam, ab94588, 1:1000), anti‐PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti‐PYGB (4A biotech, 4ab093844, 1:1000), anti‐PYGL (4A biotech, 4ab094049, 1:1000), anti‐PYGM (Abcam, ab231963, 1:1000), anti‐p‐Tau T181 (Cell Signaling Technology, 12885S, 1:1000), anti‐p‐Tau S199 (Invitrogen, 44734G, 1:1000), anti‐p‐Tau T205 (Biosource, 44‐738G, 1:1000), anti‐p‐Tau T212 (Biosource, 44‐740G, 1:1000), anti‐p‐Tau T231/S235 (Cell Signaling Technology, 20473S, 1:1000), anti‐p‐Tau S396 (Invitrogen, 44752G, 1:1000), anti‐p‐Tau S404 (Cell Signaling Technology, 20194S, 1:1000), and anti‐total tau (Invitrogen, AHB0042, 1:1000). .. Original immunoblot data are provided in Figure .

    Article Title: TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti-β-actin (CST, 8457S, 1:2000), anti-ATF6 (Abcam, ab227830, 1:1000), anti-BiP (CST, C50B12, 1:1000), antiCDK5 (Santa Cruz, sc-173, 1:1000), anti-Flag (Proteintech, 20543- 1-AP, 1:1000), anti-GAPDH (Abways, AB0038, 1:5000), anti-GFAP (Cell Signaling Technology, 3670S, 1:1000), anti-GFP (Proteintech, 50430-2-AP, 1:1000), anti-GluA2 (CST, 13607S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-HA (Proteintech, S1064-2AP, 1:1000), anti-HSC70 (Proteintech, 10654-1-AP, 1:1000), anti-Iba1 (Wako, 016-20001, 1:500), anti-LAMP2A (Abcam, ab18528, 1:1000), anti-LC3B (CST, 3868, 1:500), anti-myc (CST, 2276S, 1:1000), antip35/25 (CST, 2680, 1:1000), anti-PERK (CST, D11A8, 1:1000), antiPP1α (Thermo, 43-8100, 1:1000), anti-PP2A-α (ABclonal, A6702, 1:1000), anti-PP2B-Aα (Santa Cruz, sc-17808, 1:1000), anti-pPERK (CST, 16F8, 1:1000), anti-pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti-pS212 tau (Biosource, 44-740G, 1:1000), anti-pS396 tau (Invitrogen, 44752G, 1:1000), anti-pT216-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti-TMEM59 (ABclonal, WG-03224D, 1:1000), and antiXBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase-conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: TMEM59 deficiency activates chaperone‐mediated autophagy and ameliorates disease‐like pathologies in tauopathy model mice
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti‐β‐actin (CST, 8457S, 1:2000), anti‐ATF6 (Abcam, ab227830, 1:1000), anti‐BiP (CST, C50B12, 1:1000), anti‐CDK5 (Santa Cruz, sc‐173, 1:1000), anti‐Flag (Proteintech, 20543‐1‐AP, 1:1000), anti‐GAPDH (Abways, AB0038, 1:5000), anti‐GFAP (Cell Signaling Technology, 3670S, 1:1000), anti‐GFP (Proteintech, 50430‐2‐AP, 1:1000), anti‐GluA2 (CST, 13607S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐HA (Proteintech, S1064‐2‐AP, 1:1000), anti‐HSC70 (Proteintech, 10654‐1‐AP, 1:1000), anti‐Iba1 (Wako, 016‐20001, 1:500), anti‐LAMP2A (Abcam, ab18528, 1:1000), anti‐LC3B (CST, 3868, 1:500), anti‐myc (CST, 2276S, 1:1000), anti‐p35/25 (CST, 2680, 1:1000), anti‐PERK (CST, D11A8, 1:1000), anti‐PP1α (Thermo, 43‐8100, 1:1000), anti‐PP2A‐α (ABclonal, A6702, 1:1000), anti‐PP2B‐Aα (Santa Cruz, sc‐17808, 1:1000), anti‐pPERK (CST, 16F8, 1:1000), anti‐pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti‐pS212 tau (Biosource, 44‐740G, 1:1000), anti‐pS396 tau (Invitrogen, 44752G, 1:1000), anti‐pT216‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti‐TMEM59 (ABclonal, WG‐03224D, 1:1000), and anti‐XBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase‐conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure
    Article Snippet: Finally, protein visualization was conducted using the AI-800 imaging system (General Electric Company, United States), and the optical density values of each band were quantitatively analyzed using ImageJ software.and the optical density values of each band were quantitatively analyzed using ImageJ software. ... Primary antibody with the following proteins: anti-p-PKA (Ser133, 5661, 1:1,000, Cell Signaling Technology); anti-PKA (ab32514, 1:1,000, Abcam); anti-p-CREB (Ser133, ab32096, 1:1,000, Abcam); manti-CREB (ab32515, 1:1,000, Abcam); anti-BDNF (ab108319, 1:1,000, Abcam); anti-p-TrkB (ab229908, 1:1,000, Abcam); anti-TrkB (ab187041, 1:2,000, Abcam); anti-PSD95 (20665-1-AP, 1:1,000, Proteintech); anti-Synaptophysin (36406S, 1:1,000, Cell Signaling Technology); anti-NR2A (ab124913, 1:1,000, Abcam); anti-NR2B (ab65783, 1; 1,000, Abcam); anti-GluA1 (13185S, 1:1,000, Cell Signaling Technology); anti-GluA2 (13607S, 1:1,000, Cell Signaling Technology); anti-β-tubulin (AC021, 1:5,000, ABclonal); anti-GAPDH (60004-1-Ig, 1:5,000, Proteintech).

    Article Title: Metaplastic priming enables non-ionotropic NMDA receptor-mediated synaptic depotentiation in the hippocampus
    Article Snippet: Membranes were briefly stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature.stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature. ... The blotted proteins were then probed with moloclonal anti-GluA1 (1:1000, Cell Signaling Technology (CST), Danvers, Massachusetts, United States, cat nr #13185, RRID: AB_2732897), anti-GluA2 (1:1000, CST, cat nr #13607, RRID: AB_2650557), anit-GluA1-Ser831 (1:1000, CST, 75574, RRID: AB_2799873), anti-GluA1-Ser845 (1:1000, CST, 8084, RRID: AB_10860773) or anti-GAPDH (1:12000, CST, cat nr #2118, RRID: AB_561053) overnight at 4 0 C in 5% bovine serum albumin (BSA) in TBS-T.. Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).

    Article Title: Chronic stress induces Alzheimer’s disease-like pathologies through DNA damage-Chk1-CIP2A signaling
    Article Snippet: The primary antibodies used in this research were as follows: anti-γH2A.X (ab26350, Abcam; 80312S, Cell Signaling Technology), anti-NeuN (26975-1-AP, Proteintech), anti-GFAP (12389S, Cell Signaling Technology), anti-Iba1 (ab178846, Abcam), anti-Chk1-pS317 (12302S, Cell Signaling Technology), anti-Chk1-pS345 (39233, Gene Tex; A21009, Abclonal), anti-Chk1 (A7653, Abclonal), anti-CIP2A (A12267, Abclonal), anti-Tau-pT231 (R381181, Zen-Bioscience), anti-Tau-pS396 (381213, Zen-Bioscience), anti-Tau-pS404 (11112, SAB), Tau-5 (ab80579, Abcam), anti-APP-pT668 (6986S, Cell Signaling Technology), anti-APP (60,342–1-Ig, Proteintech), anti-PSD95 (36233S, Cell Signaling Technology; 30255-1-AP, Proteintech), anti-Synapsin- I (5297S, Cell Signaling Technology), anti-GluA1 (13185S, Cell Signaling Technology), anti-GluA2 (13607S, Cell Signaling Technology), anti-β-actin (AC026, Abclonal).. The second antibodies for Western blotting were purchased from LICOR-Biosciences (Cat#926-32210, IRDye-800CW Goat anti-Mouse IgG Secondary Antibody; Cat#926-32211, IRDye-800CW Goat anti-Rabbit IgG Secondary Antibody).

    Article Title: Chronic Lithium Treatment Alters NMDA and AMPA Receptor Synaptic Availability and Dendritic Spine Organization in the Rat Hippocampus
    Article Snippet: 9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.. 13185, RRID: AB_2732897), anti-GluA2 (1:1000, Cell Signaling Technology, cod.. 5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.

    Expressing:

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection.
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti-α-tubulin (PTM, 5442, 1:10000), anti-β-actin (Abclonal, AC026, 1:10000), anti-Caspase-3 (Cell Signaling Technology, 9662S, 1:1000), anti-Cleaved-Caspase3 (Cell Signaling Technology, 9664S, 1:1000), anti-Cleaved-PARP (Cell Signaling Technology, 9544S, 1:1000), anti-GLAST (Proteintech, 20785-1-AP, 1:1000), anti-GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti-GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti-GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti-GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti-GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-p-GSK3β (Proteintech, 17517-1-AP, 1:1000), anti-GYS1 (4A biotech, 4ab086436, 1:1000), anti-PARP (Cell Signaling Technology, 9532S, 1:1000), anti-PSD93 (Abcam, ab94588, 1:1000), anti-PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti-PYGB (4A biotech, 4ab093844, 1:1000), anti-PYGL (4A biotech, 4ab094049, 1:1000), anti-PYGM (Abcam, ab231963, 1:1000), RESEARCH INCONTEXT 1. .. Systematic review: We reviewed prior studies examining astrocytic metabolism in neurodegenerati

    Article Title: Astrocytic PYGM attenuates tau pathology by promoting lactate‐mediated neuroprotection
    Article Snippet: were detected using enhanced chemiluminescence (ECL) and quantified using ImageJ (NIH). .. Primary antibodies used were: anti‐α‐tubulin (PTM, 5442, 1:10000), anti‐β‐actin (Abclonal, AC026, 1:10000), anti‐Caspase‐3 (Cell Signaling Technology, 9662S, 1:1000), anti‐Cleaved‐Caspase‐3 (Cell Signaling Technology, 9664S, 1:1000), anti‐Cleaved‐PARP (Cell Signaling Technology, 9544S, 1:1000), anti‐GLAST (Proteintech, 20785‐1‐AP, 1:1000), anti‐GluA1 (Cell Signaling Technology, 13185S, 1:1000), anti‐GluA2 (Cell Signaling Technology, 13607S, 1:1000), anti‐GluN1 (Cell Signaling Technology, 5704S, 1:1000), anti‐GluN2A (Cell Signaling Technology, 4205S, 1:1000), anti‐GluN2B (Cell Signaling Technology, 14544S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐p‐GSK3β (Proteintech, 17517‐1‐AP, 1:1000), anti‐GYS1 (4A biotech, 4ab086436, 1:1000), anti‐PARP (Cell Signaling Technology, 9532S, 1:1000), anti‐PSD93 (Abcam, ab94588, 1:1000), anti‐PSD95 (Cell Signaling Technology, 3450S, 1:1000), anti‐PYGB (4A biotech, 4ab093844, 1:1000), anti‐PYGL (4A biotech, 4ab094049, 1:1000), anti‐PYGM (Abcam, ab231963, 1:1000), anti‐p‐Tau T181 (Cell Signaling Technology, 12885S, 1:1000), anti‐p‐Tau S199 (Invitrogen, 44734G, 1:1000), anti‐p‐Tau T205 (Biosource, 44‐738G, 1:1000), anti‐p‐Tau T212 (Biosource, 44‐740G, 1:1000), anti‐p‐Tau T231/S235 (Cell Signaling Technology, 20473S, 1:1000), anti‐p‐Tau S396 (Invitrogen, 44752G, 1:1000), anti‐p‐Tau S404 (Cell Signaling Technology, 20194S, 1:1000), and anti‐total tau (Invitrogen, AHB0042, 1:1000). .. Original immunoblot data are provided in Figure .

    Article Title: TMEM59 deficiency activates chaperone-mediated autophagy and ameliorates disease-like pathologies in tauopathy model mice.
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti-β-actin (CST, 8457S, 1:2000), anti-ATF6 (Abcam, ab227830, 1:1000), anti-BiP (CST, C50B12, 1:1000), antiCDK5 (Santa Cruz, sc-173, 1:1000), anti-Flag (Proteintech, 20543- 1-AP, 1:1000), anti-GAPDH (Abways, AB0038, 1:5000), anti-GFAP (Cell Signaling Technology, 3670S, 1:1000), anti-GFP (Proteintech, 50430-2-AP, 1:1000), anti-GluA2 (CST, 13607S, 1:1000), anti-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-HA (Proteintech, S1064-2AP, 1:1000), anti-HSC70 (Proteintech, 10654-1-AP, 1:1000), anti-Iba1 (Wako, 016-20001, 1:500), anti-LAMP2A (Abcam, ab18528, 1:1000), anti-LC3B (CST, 3868, 1:500), anti-myc (CST, 2276S, 1:1000), antip35/25 (CST, 2680, 1:1000), anti-PERK (CST, D11A8, 1:1000), antiPP1α (Thermo, 43-8100, 1:1000), anti-PP2A-α (ABclonal, A6702, 1:1000), anti-PP2B-Aα (Santa Cruz, sc-17808, 1:1000), anti-pPERK (CST, 16F8, 1:1000), anti-pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti-pS212 tau (Biosource, 44-740G, 1:1000), anti-pS396 tau (Invitrogen, 44752G, 1:1000), anti-pT216-GSK3β (Proteintech, 51065-1-AP, 1:1000), anti-total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti-TMEM59 (ABclonal, WG-03224D, 1:1000), and antiXBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase-conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: TMEM59 deficiency activates chaperone‐mediated autophagy and ameliorates disease‐like pathologies in tauopathy model mice
    Article Snippet: Ten to twenty micrograms of protein lysates were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blotting.. The blots were immunoblotted with primary antibodies, including: anti‐β‐actin (CST, 8457S, 1:2000), anti‐ATF6 (Abcam, ab227830, 1:1000), anti‐BiP (CST, C50B12, 1:1000), anti‐CDK5 (Santa Cruz, sc‐173, 1:1000), anti‐Flag (Proteintech, 20543‐1‐AP, 1:1000), anti‐GAPDH (Abways, AB0038, 1:5000), anti‐GFAP (Cell Signaling Technology, 3670S, 1:1000), anti‐GFP (Proteintech, 50430‐2‐AP, 1:1000), anti‐GluA2 (CST, 13607S, 1:1000), anti‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐HA (Proteintech, S1064‐2‐AP, 1:1000), anti‐HSC70 (Proteintech, 10654‐1‐AP, 1:1000), anti‐Iba1 (Wako, 016‐20001, 1:500), anti‐LAMP2A (Abcam, ab18528, 1:1000), anti‐LC3B (CST, 3868, 1:500), anti‐myc (CST, 2276S, 1:1000), anti‐p35/25 (CST, 2680, 1:1000), anti‐PERK (CST, D11A8, 1:1000), anti‐PP1α (Thermo, 43‐8100, 1:1000), anti‐PP2A‐α (ABclonal, A6702, 1:1000), anti‐PP2B‐Aα (Santa Cruz, sc‐17808, 1:1000), anti‐pPERK (CST, 16F8, 1:1000), anti‐pS202/T205 tau (AT8, Invitrogen, MN1020, 1:500), anti‐pS212 tau (Biosource, 44‐740G, 1:1000), anti‐pS396 tau (Invitrogen, 44752G, 1:1000), anti‐pT216‐GSK3β (Proteintech, 51065‐1‐AP, 1:1000), anti‐total tau (Tau5, Invitrogen, AHB0042, 1:1000), anti‐TMEM59 (ABclonal, WG‐03224D, 1:1000), and anti‐XBP1 (Abcam, ab220783, 1:1000).. Secondary antibodies used were horseradish peroxidase‐conjugated second antibodies (Thermo Fisher Scientific, 31430 or 31460; 1:5000).

    Article Title: The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure
    Article Snippet: Finally, protein visualization was conducted using the AI-800 imaging system (General Electric Company, United States), and the optical density values of each band were quantitatively analyzed using ImageJ software.and the optical density values of each band were quantitatively analyzed using ImageJ software. ... Primary antibody with the following proteins: anti-p-PKA (Ser133, 5661, 1:1,000, Cell Signaling Technology); anti-PKA (ab32514, 1:1,000, Abcam); anti-p-CREB (Ser133, ab32096, 1:1,000, Abcam); manti-CREB (ab32515, 1:1,000, Abcam); anti-BDNF (ab108319, 1:1,000, Abcam); anti-p-TrkB (ab229908, 1:1,000, Abcam); anti-TrkB (ab187041, 1:2,000, Abcam); anti-PSD95 (20665-1-AP, 1:1,000, Proteintech); anti-Synaptophysin (36406S, 1:1,000, Cell Signaling Technology); anti-NR2A (ab124913, 1:1,000, Abcam); anti-NR2B (ab65783, 1; 1,000, Abcam); anti-GluA1 (13185S, 1:1,000, Cell Signaling Technology); anti-GluA2 (13607S, 1:1,000, Cell Signaling Technology); anti-β-tubulin (AC021, 1:5,000, ABclonal); anti-GAPDH (60004-1-Ig, 1:5,000, Proteintech).

    Article Title: Metaplastic priming enables non-ionotropic NMDA receptor-mediated synaptic depotentiation in the hippocampus
    Article Snippet: Membranes were briefly stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature.stained with 0.1% Ponceau and then incubated in blocking buffer (5% milk in Tris-buffered saline with Tween20 (TBS-T; 20 mM Tris, 150 mM NaCl, 0.1% Tween20)) for 1 hour at room temperature. ... The blotted proteins were then probed with moloclonal anti-GluA1 (1:1000, Cell Signaling Technology (CST), Danvers, Massachusetts, United States, cat nr #13185, RRID: AB_2732897), anti-GluA2 (1:1000, CST, cat nr #13607, RRID: AB_2650557), anit-GluA1-Ser831 (1:1000, CST, 75574, RRID: AB_2799873), anti-GluA1-Ser845 (1:1000, CST, 8084, RRID: AB_10860773) or anti-GAPDH (1:12000, CST, cat nr #2118, RRID: AB_561053) overnight at 4 0 C in 5% bovine serum albumin (BSA) in TBS-T.. Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).Following primary antibody incubation, membranes were washed in 1 X TBS-T (3 x 10 minutes).

    Article Title: Chronic stress induces Alzheimer’s disease-like pathologies through DNA damage-Chk1-CIP2A signaling
    Article Snippet: The primary antibodies used in this research were as follows: anti-γH2A.X (ab26350, Abcam; 80312S, Cell Signaling Technology), anti-NeuN (26975-1-AP, Proteintech), anti-GFAP (12389S, Cell Signaling Technology), anti-Iba1 (ab178846, Abcam), anti-Chk1-pS317 (12302S, Cell Signaling Technology), anti-Chk1-pS345 (39233, Gene Tex; A21009, Abclonal), anti-Chk1 (A7653, Abclonal), anti-CIP2A (A12267, Abclonal), anti-Tau-pT231 (R381181, Zen-Bioscience), anti-Tau-pS396 (381213, Zen-Bioscience), anti-Tau-pS404 (11112, SAB), Tau-5 (ab80579, Abcam), anti-APP-pT668 (6986S, Cell Signaling Technology), anti-APP (60,342–1-Ig, Proteintech), anti-PSD95 (36233S, Cell Signaling Technology; 30255-1-AP, Proteintech), anti-Synapsin- I (5297S, Cell Signaling Technology), anti-GluA1 (13185S, Cell Signaling Technology), anti-GluA2 (13607S, Cell Signaling Technology), anti-β-actin (AC026, Abclonal).. The second antibodies for Western blotting were purchased from LICOR-Biosciences (Cat#926-32210, IRDye-800CW Goat anti-Mouse IgG Secondary Antibody; Cat#926-32211, IRDye-800CW Goat anti-Rabbit IgG Secondary Antibody).

    Article Title: Chronic Lithium Treatment Alters NMDA and AMPA Receptor Synaptic Availability and Dendritic Spine Organization in the Rat Hippocampus
    Article Snippet: 9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.9197, RRID: AB_331277), anti- GluA1 (1:1000, Cell Signaling Technology, cod.. 13185, RRID: AB_2732897), anti-GluA2 (1:1000, Cell Signaling Technology, cod.. 5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.5306, RRID: AB_10622024), anti-GluA3 (1:1000, Millipore, cod.



    Similar Products

    95
    Antibodies Inc anti-glua2-glur2 glutamate receptor antibody
    Anti Glua2 Glur2 Glutamate Receptor Antibody, supplied by Antibodies Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/Anti-GluA2-GluR2+Glutamate+Receptor+Antibody/custom%4075-002%4042571788
    Average 95 stars, based on 1 article reviews
    anti-glua2-glur2 glutamate receptor antibody - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    93
    Alomone Labs rabbit anti glua2 gria2 alomone agc
    Rabbit Anti Glua2 Gria2 Alomone Agc, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/Anti-GluR2+(GluA2)+(extracellular)+Antibody/bio_rxiv__64898__2026__05__15__725423-147-13-15
    Average 93 stars, based on 1 article reviews
    rabbit anti glua2 gria2 alomone agc - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti pan ampar
    Anti Pan Ampar, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/AMPA+Receptor+(GluA2%2F3%2F4)+Antibody/pm41872515-78-48-51
    Average 93 stars, based on 1 article reviews
    anti pan ampar - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc claudin2
    Claudin2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/AMPA+Receptor+(GluA2%2F3%2F4)+Antibody/pm41864580-44-40-41
    Average 93 stars, based on 1 article reviews
    claudin2 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    86
    Affinity Biosciences rabbit anti glua2
    Rabbit Anti Glua2, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/anti+glua2+rabbit/pm41806666-107-19-23
    Average 86 stars, based on 1 article reviews
    rabbit anti glua2 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti glun1
    Anti Glun1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/AMPA+Receptor+2+(GluA2)+Rabbit+mAb/pm41700129-55-46-47
    Average 95 stars, based on 1 article reviews
    anti glun1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc anti glua2
    Anti Glua2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/AMPA+Receptor+1+(GluA1)+Rabbit+mAb/pm41700129-55-40-41
    Average 96 stars, based on 1 article reviews
    anti glua2 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    91
    R&D Systems anti glua2
    Anti Glua2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+glua2/GluR2+Antibody/pm41507541-274-24-26
    Average 91 stars, based on 1 article reviews
    anti glua2 - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    Image Search Results